Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 2077-2083

  Narayanan, Govindarajan ^a   Barbery, Katuzka ^a   Suthar, Rekha ^a   Guerrero, Gabriella ^a   Arora, Geetika ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Drug eluting beads with irinotecan; Transarterial chemoembolization

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; HYDROMORPHONE; IRINOTECAN; LIDOCAINE; MICROSPHERE; MORPHINE; OXALIPLATIN;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALGESIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CONTRAST ENHANCEMENT; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING BEAD; DRUG RESPONSE; DRUG SAFETY; ELECTROPORATION; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; INJECTION SITE PAIN; INSOMNIA; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTATIC COLORECTAL CANCER; NAUSEA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PRURITUS; RADIOFREQUENCY ABLATION; RECTUM CANCER; RETROSPECTIVE STUDY; SIDE EFFECT; THORAX PAIN; TRANSARTERIAL CHEMOEMBOLIZATION; VOMITING;

COLORECTAL CANCER; DRUG ELUTING BEADS WITH IRINOTECAN; TRANSARTERIAL CHEMOEMBOLIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84878206056     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fiorentini G, Aliberti C, Turrisi G, Del Conte A, Rossi S, Benea G and Giovanis P: Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: Results of a phase II clinical study. In Vivo 21(6):1085-1092, 2007. (Pubitemid 350286341)
2. Martin, RCG, Joshi J, Robbins K, Tomalty D, O'Hara R and Tatum C: Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan: Multi-institutional registry. J Oncol 29: 1-6, 2009.
3. Chong G and Cunningham D: Improving long-term outcomes for patients with liver metastases from colorectal cancer. J Clin Oncol 23(36): 9063-9066, 2005.
4. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM and McWilliams RR: Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy. J Clin Oncol 27(22): 3677-3683, 2009.
5. Zorzi D, Mullen J, Abdalla E, Pawlik T, Andres A, Muratore A, Curley S, Mentha G, Capussotti L and Vauthey J: Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10(1): 86-94, 2006. (Pubitemid 41820593)
6. Reddy S, Pawlik T, Zorzi D, Gleisner A, Ribero D, Assumpcao L, Barbas A, Abdalla E, Choti M, Vauthey J, Ludwig K, Mantyh C, Morse M and Clary B: Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14(12): 3481-3491, 2007. (Pubitemid 350160107)
7. Martin RC, Robbins K, Tomalty D, O'Hara R, Bosnjakovic P, Padr R, Rocek M, Slauf F, Scupchenko A and Tatum C: Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol. 2009 Nov 3: 7:80. Available at http://www.wjso.com/content/7/1/80.
8. Kelly H and Goldberg R: Systemic therapy for metastatic colorectal cancer: Current options, current evidence. J Clin Oncol 23(20): 4553-4560, 2005. (Pubitemid 46196586)
9. Karapetis C, Khambata-Ford S, Jonker D, O'Callaghan C, Tu D, Tebbutt N, Simes R, Chalchal H, Shapiro J, Robitaille S, Price T, Shepherd L, Au H, Langer C, Moore M and Zalcberg J: K-RAS mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359(17): 1757-1765, 2008.
10. Lencioni R and Llovet J: Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52-60, 2010.
11. Vogl TJ, Gruber T, Balzer JO, Eichler K, Hammerstingl R and Zangos S: Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: Prospective study. Radiology 250(1): 281-289, 2009.
12. Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger T, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C, Chevallier P and Lencioni R: Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1): 41-52, 2010.
13. Aliberti C, Tilli M, Benea G and Fiorentini G: Trans-arterial Chemoembolization of liver metastases from colorectal cancer using irinotecan-eluting beads: Preliminary results. Anticancer Res 26(5B): 3793-3796, 2006.
14. Fiorentini G, Aliberti C, Tilli M, Mulazzani L, Graziano F, Giordani P, Mambrini A, Montagnani F, Alessandroni P, Catalano V and Coschiera P: Intra-arterial Infusion of Irinotecan-loaded Drug-eluting Beads (DEBIRI) versus Intravenous Therapy (FOLFIRI) for Hepatic Metastases from Colorectal Cancer:Final Results of a Phase III Study. Anticancer Res 32(4):1387-1396, 2012.